MSD plans to occupy cervical cancer vaccine market using ‘Gardasil9’

Published: 2016-08-19 14:48:30

Updated: 2016-08-19 14:48:30

Since cervical cancer vaccines will be included in the National Immunization Program(NIP) from this June, the private cervical cancer vaccine market is also expected to get enlarged. MSD Korea is planning to actively launch an upgraded vaccine of Gardasil,‘Gardasil9,’ and own peerless market shares in the private vaccine market.

Gardasil9 which has been vaccinated since July is an ungraded vac...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.